Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System (2015)
- Authors:
- USP affiliated authors: PEREIRA, LEONARDO RÉGIS LEIRA - FCFRP ; PERDONÁ, GLEICI DA SILVA CASTRO - FMRP ; NUNES, ALTACILIO APARECIDO - FMRP ; OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; PERIA, FERNANDA MARIS - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.4172/2329-6771.1000136
- Subjects: NEOPLASIAS COLORRETAIS; QUIMIOTERAPIA; ASSISTÊNCIA À SAÚDE; SISTEMA ÚNICO DE SAÚDE
- Language: Inglês
- Imprenta:
- Publisher place: Los Angeles
- Date published: 2015
- Source:
- Título do periódico: Journal of Integrative Oncology
- ISSN: 2329-6771
- Volume/Número/Paginação/Ano: v. 4, n. 2, p. 1000136-1 - 1000136-5, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
UNGARI, Andrea Queiróz et al. Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System. Journal of Integrative Oncology, v. 4, n. 2, p. 1000136-1 - 1000136-5, 2015Tradução . . Disponível em: https://doi.org/10.4172/2329-6771.1000136. Acesso em: 19 abr. 2024. -
APA
Ungari, A. Q., Pereira, L. R. L., Perdoná, G. da S. C., Bettim, B. B., Nunes, A. A., Rapatoni, L., et al. (2015). Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System. Journal of Integrative Oncology, 4( 2), 1000136-1 - 1000136-5. doi:10.4172/2329-6771.1000136 -
NLM
Ungari AQ, Pereira LRL, Perdoná G da SC, Bettim BB, Nunes AA, Rapatoni L, Oliveira HF de, Peria FM. Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System [Internet]. Journal of Integrative Oncology. 2015 ; 4( 2): 1000136-1 - 1000136-5.[citado 2024 abr. 19 ] Available from: https://doi.org/10.4172/2329-6771.1000136 -
Vancouver
Ungari AQ, Pereira LRL, Perdoná G da SC, Bettim BB, Nunes AA, Rapatoni L, Oliveira HF de, Peria FM. Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System [Internet]. Journal of Integrative Oncology. 2015 ; 4( 2): 1000136-1 - 1000136-5.[citado 2024 abr. 19 ] Available from: https://doi.org/10.4172/2329-6771.1000136 - Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school
- Capecitabine/oxaliplatin (XELOX) versus XELOX plus bevacizumab (XELOX + bev) cost-effectiveness for metastatic colorectal cancer (mCRC) in first line treatment: a Brazilian public hospital analysis
- Intensity modulated radiotherapy (IMRT) for patients of the Brazilian unified health system (SUS): an analysis of 508 treatments two years after the technique implementation
- On the comparison of risk od death according to different stages of breast cancer via the long-term exponetiated Weibull hazard model
- Longitudinal assessment of nutritional risk in patients under chemo or radiotherapy
- Influência dos fatores de risco pós prostatectomia radical na recidiva bioquímica no câncer de próstata
- Fatigue in patients with colorectal cancer treated with capecitabine and oxaliplatin
- Pelvic symptoms after radiotherapy in prostate cancer: a cross-sectional study
- Analysis of practice of drugs conciliation in elderly patients with cancer
- A mechanistic breast cancer survival modelling through the axillary lymph node chain
Informações sobre o DOI: 10.4172/2329-6771.1000136 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
